BREYANZI Trademark

Trademark Overview

On Wednesday, August 7, 2019, a trademark application was filed for BREYANZI with the United States Patent and Trademark Office. The USPTO has given the BREYANZI trademark a serial number of 88569196. The federal status of this trademark filing is REGISTERED as of Tuesday, August 30, 2022. This trademark is owned by Celgene Corporation. The BREYANZI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
breyanzi

General Information

Serial Number88569196
Word MarkBREYANZI
Filing DateWednesday, August 7, 2019
Status700 - REGISTERED
Status DateTuesday, August 30, 2022
Registration Number6834335
Registration DateTuesday, August 30, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 22, 2019

Trademark Statements

Description of MarkThe mark consists of "BREYANZI" in dark blue font with an orange dot over the "I" with a sunburst design behind and above the "ZI" with half of the dots in the upper side in dark blue dots and the other half of the dots in the lower side in light blue dots.
Goods and ServicesPharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
Indication of Colors claimedThe color(s) dark blue, light blue, and orange is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 23, 2019
Primary Code005
First Use Anywhere DateFriday, February 5, 2021
First Use In Commerce DateFriday, February 5, 2021

Trademark Owner History

Party NameJUNO THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98109
Party NameJUNO THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98109
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Tuesday, August 30, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 30, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 26, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, July 25, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 30, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 15, 2022USE AMENDMENT FILED
Wednesday, June 15, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, December 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 10, 2021SOU EXTENSION 4 GRANTED
Friday, December 10, 2021SOU EXTENSION 4 FILED
Friday, December 10, 2021TEAS EXTENSION RECEIVED
Friday, June 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 16, 2021SOU EXTENSION 3 GRANTED
Wednesday, June 16, 2021SOU EXTENSION 3 FILED
Wednesday, June 16, 2021TEAS EXTENSION RECEIVED
Thursday, March 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 24, 2021SOU EXTENSION 2 GRANTED
Thursday, December 17, 2020SOU EXTENSION 2 FILED
Tuesday, March 23, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 22, 2021NOTICE OF REVIVAL - E-MAILED
Thursday, January 21, 2021EXTENSION RECEIVED WITH TEAS PETITION
Thursday, January 21, 2021PETITION TO REVIVE-GRANTED
Thursday, January 21, 2021TEAS PETITION TO REVIVE RECEIVED
Wednesday, January 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 20, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, January 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 19, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 18, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, April 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 15, 2020SOU EXTENSION 1 GRANTED
Wednesday, April 15, 2020SOU EXTENSION 1 FILED
Wednesday, April 15, 2020TEAS EXTENSION RECEIVED
Tuesday, December 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 30, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 17, 2019ASSIGNED TO EXAMINER
Saturday, August 24, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, August 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 10, 2019NEW APPLICATION ENTERED

Related Keywords

breyanzi preparations pharmaceutical treatment immunotherapy biological cell therapy tumors including system